Emtricitabine-Tenofovir Treatment Report

Category: Prescription Drugs

Most Popular Types: Truvada

false

What is Emtricitabine-Tenofovir?

An example of Emtricitabine-Tenofovir

Emtricitabine and tenofovir is an antiviral medication that prevents human immunodeficiency virus (HIV) from reproducing in your body. Emtricitabine and tenofovir treats HIV, which causes acquired immunodeficiency syndrome (AIDS).

Reported Purpose & Perceived Effectiveness

Reasons and Perceived effectiveness
Perceived Effectiveness
Purpose # of patients # of patients with evaluations
Major
Moderate
Slight
None
Can’t tell
315 82 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none Efficacy_cant_tell
6 1 Efficacy_cant_tell
3 0
2 0
1 0
1 0

See all 353 patients currently taking Emtricitabine-Tenofovir

Mouse over the table for more information

Reported Dosages

Frequently reported dosages based on patients currently taking Emtricitabine-Tenofovir. See all 23 dosages

  daily 1 daily 1 other daily 1 mg daily 100 mg daily 200 mg-300 mg m,w,f 200 mg daily 245 mg daily 300 mg daily 200 mg-300 mg daily
  31 Number of Patients: 31 12 Number of Patients: 12 3 Number of Patients: 3 4 Number of Patients: 4 3 Number of Patients: 3 2 Number of Patients: 2 12 Number of Patients: 12 3 Number of Patients: 3 12 Number of Patients: 12 254 Number of Patients: 254  

Reported Stop Reasons

Why Patients Stopped Taking Emtricitabine-Tenofovir (multiple reasons could be selected)
Reason # Patients Percentage of patients
Doctor's advice 28   Doctor's advice: 42%
Other 17   Other: 26%
Side effects too severe 12   Side effects too severe: 18%
Course of treatment ended 7   Course of treatment ended: 11%
Did not seem to work 3   Did not seem to work: 5%
Expense 3   Expense: 5%
Not indicated 2   Not indicated: 3%
Personal research 1   Personal research: 2%
Change in health plan coverage 1   Change in health plan coverage: 2%

See all 62 patients who’ve stopped taking Emtricitabine-Tenofovir

Currently Taking Emtricitabine-Tenofovir

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0

Stopped Taking Emtricitabine-Tenofovir

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Reported Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Adherence of Emtricitabine-Tenofovir

Always
68 81%
Usually
11 13%
Sometimes
2 2%
Never
3 4%

Burden

Difficulty being on treatment

Burden of Emtricitabine-Tenofovir

Very
2 2%
Somewhat
8 10%
A little
15 18%
Not at all
59 70%

Cost

Paid out of pocket

Cost of Emtricitabine-Tenofovir

$200+
3 5%
$100-199
2 4%
$50-99
6 11%
$25-49
5 9%
< $25
39 71%

Sort by: Helpfulness | Most Recent

18 patient evaluations for Emtricitabine-Tenofovir

Purpose: HIV (Human Immunodeficiency Virus) (Started Nov 01, 2006)
Date Dosage Perceived effectiveness Side Effects Adherence Burden
Mar 11, 2013 200 mg-300 mg Daily Led_efficacy_4Led_efficacy_4Led_efficacy_4Led_efficacy_4Major NoneNoneNoneNoneNone AlwaysAlwaysAlwaysAlwaysAlways A littleA littleA littleA littleA little
Oct 17, 2012 200 mg-300 mg Daily Led_efficacy_4Led_efficacy_4Led_efficacy_4Led_efficacy_4Major NoneNoneNoneNoneNone AlwaysAlwaysAlwaysAlwaysAlways Not at allNot at allNot at allNot at allNot at all
  • Icon_thumb_off 0 helpful marks
Purpose: HIV (Human Immunodeficiency Virus) (Started Apr 18, 2012)
Date Dosage Perceived effectiveness Side Effects Adherence Burden
Aug 15, 2012 200 mg-300 mg Daily Led_efficacy_4Led_efficacy_4Led_efficacy_4Led_efficacy_4Major NoneNoneNoneNoneNone AlwaysAlwaysAlwaysAlwaysAlways A littleA littleA littleA littleA little
  • Icon_thumb_off 0 helpful marks
Purpose: HIV (Human Immunodeficiency Virus) (Started Dec 05, 2011)
Date Dosage Perceived effectiveness Side Effects Adherence Burden
Feb 16, 2012   Led_efficacy_1Led_defaultLed_defaultLed_defaultNone SevereSevereSevereSevereSevere AlwaysAlwaysAlwaysAlwaysAlways SomewhatSomewhatSomewhatSomewhatSomewhat
Jan 31, 2012 200 mg-300 mg Daily ?Can't tell SevereSevereSevereSevereSevere AlwaysAlwaysAlwaysAlwaysAlways SomewhatSomewhatSomewhatSomewhatSomewhat
Date
Feb 16, 2012
Advice & Tips
Listen to your body and keep track of your reactions. I felt difficulty within two days of Truvada after 13 years of treatment.
  • Icon_thumb_off 0 helpful marks
1 2 3 4 5 6    You are at the first page First There is no previous page Prev | Next Go to the next page Last Go to the last page 

What is emtricitabine-tenofovir?

Emtricitabine and tenofovir are antiviral drugs that work by preventing HIV (human immunodeficiency virus) cells from multiplying in the body.

The combination of emtricitabine and tenofovir is used to treat HIV, which causes acquired immunodeficiency syndrome (AIDS). Emtricitabine and tenofovir is not a cure for HIV or AIDS.

Emtricitabine and tenofovir may also be used for other purposes not listed in this medication guide.


Precautions

You should not take this medication if you are allergic to emtricitabine or tenofovir.

Do not take this medication with other medicines that also contain emtricitabine or tenofovir (Atripla, Emtriva, Viread), or lamivudine (Combivir, Epivir, Epzicom, or Trizivir).

If you have certain conditions, you may need a dose adjustment or special tests to safely use this medication. Before you take emtricitabine and tenofovir, tell your doctor if you have:

  • liver disease;
  • kidney disease;
  • osteopenia (low bone mineral density); or
  • if you also have hepatitis B infection.

FDA pregnancy category B. Emtricitabine and tenofovir is not expected to be harmful to an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant during treatment.

HIV can be passed to the baby if the mother is not properly treated during pregnancy. Tell your doctor if you are pregnant or plan to become pregnant during treatment. Take all of your HIV medicines as directed to control your infection while you are pregnant.

Your name may need to be listed on an pregnancy registry if you become pregnant while using this medication. The purpose of this registry is to track the outcome of the pregnancy and delivery to evaluate whether emtricitabine and tenofovir had any effect on the baby.

You should not breast-feed while you are using emtricitabine and tenofovir. Women with HIV or AIDS should not breast-feed at all. Even if your baby is born without HIV, you may still pass the virus to the baby in your breast milk.

Some people have developed a life-threatening condition called lactic acidosis while taking emtricitabine and tenofovir. You may be more likely to develop lactic acidosis if you are overweight or have liver disease, if you are a woman, or if you have taken certain HIV or AIDS medications for a long time. Talk with your doctor about your individual risk.

Do not give this medicine to anyone under 18 without the advice of a doctor.

Avoid having unprotected sex or sharing needles, razors, or toothbrushes. Taking this medication will not prevent you from passing HIV to other people. Talk with your doctor about safe methods of preventing HIV transmission during sex. Sharing drug or medicine needles is never safe, even for a healthy person.

Back to top

Instructions

Seek emergency medical attention if you think you have used too much of this medicine. Symptoms of an emtricitabine and tenofovir overdose are not known.

Take the missed dose as soon as you remember. If it is almost time for your next dose, skip the missed dose and take the medicine at the next regularly scheduled time. Do not take extra medicine to make up the missed dose.

Back to top

Side Effects

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.

This medication may cause lactic acidosis (a build-up of lactic acid in the body, which can be fatal). Lactic acidosis can start slowly and get worse over time. Get emergency medical help if you have even mild symptoms of lactic acidosis, such as:

  • muscle pain or weakness;
  • numb or cold feeling in your arms and legs;
  • trouble breathing;
  • feeling dizzy, light-headed, tired, or very weak;
  • stomach pain, nausea with vomiting; or
  • slow or uneven heart rate.

Call your doctor at once if you have any of these other serious side effects:

  • signs of liver damage - nausea, stomach pain, low fever, loss of appetite, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes);
  • increased thirst and urination, loss of appetite, weakness, constipation;
  • urinating less than usual or not at all; or
  • signs of infection such as fever, chills, skin lesions, or cough with yellow or green mucus.

Less serious side effects may include:

  • dizziness, anxiety, depressed mood;
  • headache, tired feeling;
  • sleep problems (insomnia), strange dreams;
  • mild nausea, vomiting, diarrhea, upset stomach;
  • mild itching or skin rash;
  • darkened skin on the palms of your hands or the soles of your feet;
  • joint pain, back pain;
  • numbness or tingly feeling;
  • runny or stuffy nose, cough; or
  • changes in the shape or location of body fat (especially in your arms, legs, face, neck, breasts, and waist).

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Back to top

Interactions

This medication can be harmful to the kidneys, and this effect is increased when emtricitabine and tenofovir is used together with other medicines that can harm the kidneys. Before taking this medication, tell your doctor if you have recently used:

  • lithium (Lithobid);
  • methotrexate (Rheumatrex, Trexall);
  • pain or arthritis medicines such as aspirin (Anacin, Excedrin), acetaminophen (Tylenol), diclofenac (Cataflam, Voltaren), etodolac (Lodine), ibuprofen (Advil, Motrin), indomethacin (Indocin), naproxen (Aleve, Naprosyn), and others;
  • medicines used to prevent organ transplant rejection, such as cyclosporine (Gengraf, Neoral, Sandimmune), sirolimus (Rapamune) or tacrolimus (Prograf);
  • IV antibiotics such as amphotericin B (Fungizone, AmBisome, Amphotec, Abelcet), amikacin (Amikin), bacitracin (Baci-IM), capreomycin (Capastat), gentamicin (Garamycin), kanamycin (Kantrex), streptomycin, or vancomycin (Vancocin, Vancoled);
  • antiviral medicines such as adefovir (Hepsera), cidofovir (Vistide), or foscarnet (Foscavir); or
  • cancer medicine such as aldesleukin (Proleukin), carmustine (BiCNU, Gliadel), cisplatin (Platinol), ifosfamide (Ifex), oxaliplatin (Eloxatin), plicamycin (Mithracin), streptozocin (Zanosar), or tretinoin (Vesanoid).

You may need dose adjustments or special tests when taking any of these medications together with emtricitabine and tenofovir.

Other medications that can affect emtricitabine and tenofovir include:

  • the herpes medications acyclovir (Zovirax) or valacyclovir (Valtrex);
  • medications to treat cytomegalovirus (CMV) such as cidofovir (Vistide), ganciclovir (Cytovene) or valganciclovir (Valcyte); or
  • certain other HIV medicines such as atazanavir (Reyataz), didanosine (Videx), indinavir (Crixivan), saquinavir (Invirase), lopinavir/ritonavir (Kaletra), or ritonavir (Norvir).

This list is not complete and there may be other drugs that can interact with emtricitabine and tenofovir. Tell your doctor about all the prescription and over-the-counter medications you use. This includes vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start using a new medication without telling your doctor.

Other Names

Truvada, emtricitabine-tenofovir, and tenofovir-emtricitabine

Back to top

Disclaimer

Every effort has been made to ensure that the information provided by Cerner Multum, Inc. ('Multum') is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Multum information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Multum does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Multum's drug information does not endorse drugs, diagnose patients or recommend therapy. Multum's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Multum does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 1996-2004 Cerner Multum, Inc. Version 2.05. Revision date 8/23/04

Last updated: